The latest from NuvOx

NuvOx Pharma Presents at AZ BIO White Hat Event

NuvOx Pharma Announces Issuance of a New Patent

Tucson, AZ, May 16th, 2022 - https://www.pr.com/press-release/861616 NuvOx Pharma has been issued US Patent No. 11,304,899, entitled...

NuvOx Appoints Dr. Robert King to SAB

Tucson, AZ, May 9th, 2022 – https://www.pr.com/press-release/861001 NuvOx Pharma, a clinical stage biotechnology company developing a...

NuvOx Technology Featured in Prominent Peer Review Journal

Tucson, AZ, April 19, 2022 -- https://www.pr.com/press-release/859633 NuvOx Pharma’s technology, which is developed as a first-in-class...

NuvOx Finalizes Facility Certification, Poising for Phase IIb Trials

Tucson, AZ, April 17, 2022 -- https://www.pr.com/press-release/859467 NuvOx Pharma, a clinical stage biotechnology company developing a...